President Donald Trump met with pharma executives in a meeting that had once been billed as a scolding over high prices. But now that the industry is needed to help develop a vaccine for the emerging pandemic, Trump has taken a more congenial tone with the executives. Meanwhile, Stat takes a closer look at where everyone stands on developing coronavirus-related drugs and vaccines.

from Kaiser Health News https://ift.tt/2PYlxtZ

Related Posts:

0 comments:

Post a Comment

Popular Posts